Garvan and the Medical Research Council's Laboratory of Molecular Biology (LMB), based in Cambridge, have set up the Geoffrey Grigg Travelling Fellowship aimed at enabling short scientific exchange visits between the two institutions.

The Fellowship commemorates Geoffrey Grigg, who was an Australian scientist, highly influential in the fields of genetics, molecular biology and DNA research and a pioneer of Australia's biotechnology industry. Geoffrey visited LMB to work with Nobel laureate Fred Sanger in 1972-1974 and Sir Gregory Winter in 1988. He regularly traveled back in the 1990s as he played a key role in the founding and financing of Cambridge Antibody Technology and Domantis, two start-up biotechnology companies based on work originating in LMB.

Kip Dudgeon is the first recipient of the Geoffrey Grigg Travelling Fellowship.  Kip is a Garvan PhD student, working with Daniel Christ (formerly LMB) on the development of antibody therapeutics. He is visiting LMB until 29 June to work with Greg Winter and Peter Jones on aspects of protein engineering.